Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Trevi Therapeutics, Inc. (TRVI)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
11 Sep 2023
Delfini Lisa
Chief Financial Officer, Officer
Trevi Therapeutics, Inc.
(TRVI)
34,394
-2%
711
$2.20
$1,564.20
SELL
11 Aug 2023
Delfini Lisa
Chief Financial Officer, Officer
Trevi Therapeutics, Inc.
(TRVI)
32,814
-2%
682
$2.36
$1,609.52
SELL
11 Jul 2023
Delfini Lisa
Chief Financial Officer, Officer
Trevi Therapeutics, Inc.
(TRVI)
31,204
-2%
687
$2.34
$1,607.58
SELL
12 Jun 2023
Delfini Lisa
Chief Financial Officer, Officer
Trevi Therapeutics, Inc.
(TRVI)
29,599
-2%
610
$2.64
$1,610.40
SELL
11 Apr 2023
Delfini Lisa
Chief Financial Officer, Officer
Trevi Therapeutics, Inc.
(TRVI)
26,189
-3%
840
$1.84
$1,544.76
SELL
13 Mar 2023
Delfini Lisa
Chief Financial Officer, Officer
Trevi Therapeutics, Inc.
(TRVI)
24,737
-3%
892
$1.75
$1,563.85
SELL
13 Feb 2023
Delfini Lisa
Chief Financial Officer, Officer
Trevi Therapeutics, Inc.
(TRVI)
23,338
-26%
8,474
$2.45
$20,761.30
SELL
1 Jul 2022
TPG GP A, LLC
Former 10% Owner
Trevi Therapeutics, Inc.
(TRVI)
3,824,883
-11%
500,000
$2.89
$1,444,011.90
SELL
29 Jun 2022
TPG GP A, LLC
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
4,324,883
-9%
475,966
$2.77
$1,318,201.00
SELL
2 May 2022
TPG GP A, LLC
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
4,800,849
-0%
600
$2.70
$1,620.00
SELL
28 Apr 2022
TPG GP A, LLC
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
4,801,449
-0%
23,434
$2.75
$64,525.16
BUY
11 Apr 2022
Sonsini Peter W.
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
10,421,428
+52%
3,580,526
$1.90
$6,802,999.00
BUY
11 Apr 2022
New Enterprise Associates 16, L.P.
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
10,421,428
+33%
2,631,578
$1.90
$4,999,998.00
BUY
11 Apr 2022
Chang Carmen
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
10,421,428
+52%
3,580,526
$1.90
$6,802,999.00
BUY
11 Apr 2022
SANDELL SCOTT D
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
10,421,428
+52%
3,580,526
$1.90
$6,802,999.00
BUY
11 Apr 2022
Behbahani Ali
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
10,421,428
+52%
3,580,526
$1.90
$6,802,999.00
BUY
11 Apr 2022
Walker Paul Edward
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
10,421,428
+52%
3,580,526
$1.90
$6,802,999.00
BUY
11 Apr 2022
Florence Anthony A. Jr.
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
10,421,428
+52%
3,580,526
$1.90
$6,802,999.00
BUY
11 Apr 2022
BASKETT FOREST
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
10,421,428
+33%
2,631,578
$1.90
$4,999,998.00
BUY
11 Apr 2022
Makhzoumi Mohamad
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
10,421,428
+52%
3,580,526
$1.90
$6,802,999.00
SELL
3 Apr 2020
Sonsini Peter W.
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
5,937,998
-0%
564
$2.66
$1,500.24
SELL
3 Apr 2020
New Enterprise Associates 16, L.P.
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
5,937,998
-0%
564
$2.66
$1,500.24
SELL
3 Apr 2020
Chang Carmen
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
5,937,998
-0%
564
$2.66
$1,500.24
SELL
3 Apr 2020
SANDELL SCOTT D
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
5,937,998
-0%
564
$2.66
$1,500.24
SELL
3 Apr 2020
Behbahani Ali
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
5,937,998
-0%
564
$2.66
$1,500.24
SELL
3 Apr 2020
MAKOWER JOSHUA
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
5,937,998
-0%
564
$2.66
$1,500.24
SELL
3 Apr 2020
Walker Paul Edward
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
5,937,998
-0%
564
$2.66
$1,500.24
SELL
3 Apr 2020
Florence Anthony A. Jr.
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
5,937,998
-0%
564
$2.66
$1,500.24
SELL
3 Apr 2020
BASKETT FOREST
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
5,937,998
-0%
564
$2.66
$1,500.24
SELL
3 Apr 2020
Makhzoumi Mohamad
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
5,937,998
-0%
564
$2.66
$1,500.24
BUY
9 May 2019
Sonsini Peter W.
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
2,938,562
+570%
2,500,000
$10.00
$25,000,000.00
BUY
9 May 2019
New Enterprise Associates 16, L.P.
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
2,938,562
+570%
2,500,000
$10.00
$25,000,000.00
BUY
9 May 2019
BARRIS PETER J
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
2,938,562
+570%
2,500,000
$10.00
$25,000,000.00
BUY
9 May 2019
Chang Carmen
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
2,938,562
+570%
2,500,000
$10.00
$25,000,000.00
BUY
9 May 2019
MOTT DAVID M
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
2,938,562
+570%
2,500,000
$10.00
$25,000,000.00
BUY
9 May 2019
GOOD JENNIFER L
See Remarks, Director, Officer, 10% Owner
Trevi Therapeutics, Inc.
(TRVI)
206,204
+5%
11,250
$10.00
$112,500.00
BUY
9 May 2019
Aperture Venture Partners IV, L.P.
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
344,963
+48%
112,000
$10.00
$1,120,000.00
BUY
9 May 2019
Heffernan Michael Thomas
Director
Trevi Therapeutics, Inc.
(TRVI)
6,351
+64%
2,500
$10.00
$25,000.00
BUY
9 May 2019
Meeker David P
Director, 10% Owner
Trevi Therapeutics, Inc.
(TRVI)
352,489
+3%
11,250
$10.00
$112,500.00
BUY
9 May 2019
SANDELL SCOTT D
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
2,938,562
+570%
2,500,000
$10.00
$25,000,000.00
BUY
9 May 2019
Omega Fund V, L.P.
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
1,063,408
+82%
481,000
$10.00
$4,810,000.00
BUY
9 May 2019
Mellon Family Investment Co V
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
347,156
+40%
100,000
$10.00
$1,000,000.00
BUY
9 May 2019
Behbahani Ali
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
2,938,562
+570%
2,500,000
$10.00
$25,000,000.00
BUY
9 May 2019
Agger Mette Kirstine
Director
Trevi Therapeutics, Inc.
(TRVI)
1,151,544
+48%
375,000
$10.00
$3,750,000.00
BUY
9 May 2019
MAKOWER JOSHUA
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
2,938,562
+570%
2,500,000
$10.00
$25,000,000.00
BUY
9 May 2019
Walker Paul Edward
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
2,938,562
+570%
2,500,000
$10.00
$25,000,000.00
BUY
9 May 2019
TPG Group Holdings (SBS) Advisors, Inc.
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
6,573,000
+13%
800,000
$10.00
$8,000,000.00
BUY
9 May 2019
Richard King Mellon Foundation
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
347,157
+40%
100,000
$10.00
$1,000,000.00
BUY
9 May 2019
Florence Anthony A. Jr.
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
2,938,562
+570%
2,500,000
$10.00
$25,000,000.00
BUY
9 May 2019
VANLENT ANNE
Director
Trevi Therapeutics, Inc.
(TRVI)
25,983
+23%
5,000
$10.00
$50,000.00
BUY
9 May 2019
BASKETT FOREST
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
2,938,562
+570%
2,500,000
$10.00
$25,000,000.00
BUY
9 May 2019
Makhzoumi Mohamad
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
2,938,562
+570%
2,500,000
$10.00
$25,000,000.00
BUY
9 May 2019
Lundbeckfond Invest A/S
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
1,151,544
+48%
375,000
$10.00
$3,750,000.00
Home